Ref ID: 17703
Author:
P. Kazila*, I. Diamanti, E. Sotiriadou, V. Anagnostou, X. Meleti,
S. Kostopoulou, S. Karampa, E. Kaitsa
Author address:
Thessaloniki, GR)
Full conference title:
22nd European Congress of Clinical Microbiology and Infectious Diseases
Abstract:
Objectives: The invasive aspergillosis (IA) remains a common cause
of morbidity and mortality in immunocompromised patients, although
there is a lot of progress in diagnosis and therapeutic management. Aim
of our study is to evaluate the detection of Aspergillus antigen
galactomannan (GM) in diagnosis and following up in infected patients
of our hospital.
Methods: During the period 2008-2010, 2499 clinical samples were
examined for the detection of GM antigen. Samples (1-8/patient) were
from 422 immunocompromised hospitalized patients. Patients were
mostly neutrophenic with symptoms of infection. GM antigen was
detected by Platelia Aspergillus EIA method (Biorad, Marnes-La-
Coquette, France). Samples that had ratio (r) >0.5 were rated as
positive. Statistical analysis was made using SPSS (paired samples ttest).
Results: The positive samples were 133/2499 (5.32%). These samples
were from 71/422 (16.8%) patients. Apart from GM there were other
clinical and laboratory findings that confirmed aspergillosis. Fifty-eight
Abstract Number: R2726
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Jarod Fortwendel (US)
2024
49
n/a
-
v
Dr Takashi Umeyama (JP)
2024
48
n/a
-
v
Baptiste Bidon, Hajar Yaakoub, Arnaud Lanoue, Antoine Géry, Virginie Séguin, Claire Hoffmann Solène Le Gal, Gilles Nevez, Vincent Courdavault, Jean-Philippe Bouchara, Antonis Rokas, Gustavo H. Goldman, Jean-Pierre Gangneux, Jens C. Frisvad, Domenico Davolos, David Garon, Nicolas Papon
2024
47
n/a
-
v
Adela Martin-Vicente (US)
2024
46
n/a
-
v
Antonio Inforzato (IT)
2024
45
n/a
-
v
Takahiro Takazono (JP)
2024
44
n/a
-
v
Laurence Delhaes (FR)
2024
43
n/a
-
v
Dr Sarah Ahmed (NL)
2024
42
n/a